{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:33:11Z","timestamp":1794486791580,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":82,"publisher":"Springer New York","isbn-type":[{"value":"9781493917754","type":"print"},{"value":"9781493917761","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-1-4939-1776-1_16","type":"book-chapter","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:27:24Z","timestamp":1413332844000},"page":"213-224","source":"Crossref","is-referenced-by-count":11,"title":["Host Response Biomarkers in Sepsis: The Role of Procalcitonin"],"prefix":"10.1007","author":[{"given":"Jean-Louis","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Van Nuffelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lelubre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,24]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","volume":"38","author":"DF Gaieski","year":"2010","unstructured":"Gaieski DF, Mikkelsen ME, Band RA et al (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38:1045\u20131053","journal-title":"Crit Care Med"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/cc8872","volume":"14","author":"C Pierrakos","year":"2010","unstructured":"Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14:R15","journal-title":"Crit Care"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1097\/00003246-200004000-00057","volume":"28","author":"JL Vincent","year":"2000","unstructured":"Vincent JL (2000) Procalcitonin: THE marker of sepsis? Crit Care Med 28:1226\u20131228","journal-title":"Crit Care Med"},{"key":"16_CR4","first-page":"576","volume":"101","author":"RW Chesney","year":"1983","unstructured":"Chesney RW, McCarron DM, Haddad JG et al (1983) Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J Lab Clin Med 101:576\u2013585","journal-title":"J Lab Clin Med"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1210\/jc.2002-021444","volume":"89","author":"KL Becker","year":"2004","unstructured":"Becker KL, Nylen ES, White JC et al (2004) Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis\u2014a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512\u20131525","journal-title":"J Clin Endocrinol Metab"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","volume":"341","author":"M Assicot","year":"1993","unstructured":"Assicot M, Gendrel D, Carsin H et al (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515\u2013518","journal-title":"Lancet"},{"key":"16_CR7","first-page":"396","volume":"86","author":"B Muller","year":"2001","unstructured":"Muller B, White JC, Nylen ES et al (2001) Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86:396\u2013404","journal-title":"J Clin Endocrinol Metab"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1210\/en.2003-0854","volume":"144","author":"P Linscheid","year":"2003","unstructured":"Linscheid P, Seboek D, Nylen ES et al (2003) In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 144:5578\u20135584","journal-title":"Endocrinology"},{"key":"16_CR9","first-page":"1605","volume":"79","author":"P Dandona","year":"1994","unstructured":"Dandona P, Nix D, Wilson MF et al (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605\u20131608","journal-title":"J Clin Endocrinol Metab"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00006454-199910000-00008","volume":"18","author":"D Gendrel","year":"1999","unstructured":"Gendrel D, Raymond J, Coste J et al (1999) Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 18:875\u2013881","journal-title":"Pediatr Infect Dis J"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1128\/JCM.00655-10","volume":"48","author":"DN Gilbert","year":"2010","unstructured":"Gilbert DN (2010) Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol 48:2325\u20132329","journal-title":"J Clin Microbiol"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1741-7015-9-107","volume":"9","author":"P Schuetz","year":"2011","unstructured":"Schuetz P, Albrich WC, Mueller B (2011) Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 9:107","journal-title":"BMC Med"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00011-010-0255-8","volume":"60","author":"AP Liappis","year":"2011","unstructured":"Liappis AP, Gibbs KW, Nylen ES et al (2011) Exogenous procalcitonin evokes a pro-inflammatory cytokine response. Inflamm Res 60:203\u2013207","journal-title":"Inflamm Res"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1097\/00003246-200209000-00023","volume":"30","author":"G Hoffmann","year":"2002","unstructured":"Hoffmann G, Czechowski M, Schloesser M, Schobersberger W (2002) Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 30: 2091\u20132095","journal-title":"Crit Care Med"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/00003246-199806000-00015","volume":"26","author":"ES Nylen","year":"1998","unstructured":"Nylen ES, Whang KT, Snider RH Jr et al (1998) Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26:1001\u20131006","journal-title":"Crit Care Med"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/109629601317202678","volume":"2","author":"JM Martinez","year":"2001","unstructured":"Martinez JM, Wagner KE, Snider RH et al (2001) Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis. Surg Infect (Larchmt) 2:193\u2013202","journal-title":"Surg Infect (Larchmt)"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1097\/00003246-200210000-00021","volume":"30","author":"KE Wagner","year":"2002","unstructured":"Wagner KE, Martinez JM, Vath SD et al (2002) Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med 30: 2313\u20132321","journal-title":"Crit Care Med"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1006\/cyto.1999.0607","volume":"12","author":"G Monneret","year":"2000","unstructured":"Monneret G, Pachot A, Laroche B et al (2000) Procalcitonin and calcitonin gene-related peptide decrease LPS-induced tnf production by human circulating blood cells. Cytokine 12: 762\u2013764","journal-title":"Cytokine"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2180-12-68","volume":"12","author":"G Matera","year":"2012","unstructured":"Matera G, Quirino A, Giancotti A et al (2012) Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells. BMC Microbiol 12:68","journal-title":"BMC Microbiol"},{"key":"16_CR20","unstructured":"PCT sensitive Kryptor. Available at: \n                  http:\/\/www.procalcitonin.com\/pdf\/PCT-SENSITIVE_KRYPTOR\/ifu_825.050_en_R10_brahms-kryptor-pct-sensitive.pdf"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1309\/LMQ2GRR4QLFKHCH9","volume":"41","author":"M Jin","year":"2010","unstructured":"Jin M, Khan AI (2010) Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. Lab Med 41:173\u2013177","journal-title":"Lab Med"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0009-8981(02)00101-8","volume":"323","author":"M Meisner","year":"2002","unstructured":"Meisner M (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323:17\u201329","journal-title":"Clin Chim Acta"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/322031","volume":"184","author":"HL Preas","year":"2001","unstructured":"Preas HL, Nylen ES, Snider RH et al (2001) Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis 184: 373\u2013376","journal-title":"J Infect Dis"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","volume":"164","author":"S Harbarth","year":"2001","unstructured":"Harbarth S, Holeckova K, Froidevaux C et al (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396\u2013402","journal-title":"Am J Respir Crit Care Med"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10156-005-0388-9","volume":"11","author":"N Aikawa","year":"2005","unstructured":"Aikawa N, Fujishima S, Endo S et al (2005) Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 11:152\u2013159","journal-title":"J Infect Chemother"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/154405910808700707","volume":"87","author":"CW Bassim","year":"2008","unstructured":"Bassim CW, Redman RS, DeNucci DJ et al (2008) Salivary procalcitonin and periodontitis in diabetes. J Dent Res 87:630\u2013634","journal-title":"J Dent Res"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.2106\/JBJS.G.00265","volume":"90","author":"JA Forsberg","year":"2008","unstructured":"Forsberg JA, Elster EA, Andersen RC et al (2008) Correlation of procalcitonin and cytokine expression with dehiscence of wartime extremity wounds. J Bone Joint Surg Am 90: 580\u2013588","journal-title":"J Bone Joint Surg Am"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s15010-001-1165-z","volume":"29","author":"M Jereb","year":"2001","unstructured":"Jereb M, Muzlovic I, Hojker S, Strle F (2001) Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection 29:209\u2013212","journal-title":"Infection"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1258\/acb.2007.007133","volume":"45","author":"CF Linssen","year":"2008","unstructured":"Linssen CF, Bekers O, Drent M, Jacobs JA (2008) C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 45:293\u2013298","journal-title":"Ann Clin Biochem"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","volume":"13","author":"C Wacker","year":"2013","unstructured":"Wacker C, Prkno A, Brunkhorst FM, Schlattmann P (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13: 426\u2013435","journal-title":"Lancet Infect Dis"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1378\/chest.09-2927","volume":"138","author":"JM Daniels","year":"2010","unstructured":"Daniels JM, Schoorl M, Snijders D et al (2010) Procalcitonin vs. C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 138: 1108\u20131115","journal-title":"Chest"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/cc4866","volume":"10","author":"S Gaini","year":"2006","unstructured":"Gaini S, Koldkjaer OG, Pedersen C, Pedersen SS (2006) Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 10:R53","journal-title":"Crit Care"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/00003246-199903000-00024","volume":"27","author":"H Ugarte","year":"1999","unstructured":"Ugarte H, Silva E, Mercan D et al (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27: 498\u2013504","journal-title":"Crit Care Med"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1097\/01.CCM.0000063440.19188.ED","volume":"31","author":"A Luzzani","year":"2003","unstructured":"Luzzani A, Polati E, Dorizzi R et al (2003) Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31: 1737\u20131741","journal-title":"Crit Care Med"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1097\/01.CCM.0000226413.54364.36","volume":"34","author":"B Uzzan","year":"2006","unstructured":"Uzzan B, Cohen R, Nicolas P et al (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34:1996\u20132003","journal-title":"Crit Care Med"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","volume":"39","author":"L Simon","year":"2004","unstructured":"Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206\u2013217","journal-title":"Clin Infect Dis"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1097\/CCM.0b013e31819ffd5b","volume":"37","author":"GP Castelli","year":"2009","unstructured":"Castelli GP, Pognani C, Cita M, Paladini R (2009) Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 37:1845\u20131849","journal-title":"Crit Care Med"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10238-012-0191-8","volume":"13","author":"H Brodska","year":"2013","unstructured":"Brodska H, Malickova K, Adamkova V et al (2013) Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med 13:165\u2013170","journal-title":"Clin Exp Med"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2334-8-38","volume":"8","author":"PE Charles","year":"2008","unstructured":"Charles PE, Ladoire S, Aho S et al (2008) Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 8:38","journal-title":"BMC Infect Dis"},{"key":"16_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2334-9-49","volume":"9","author":"PE Charles","year":"2009","unstructured":"Charles PE, Kus E, Aho S et al (2009) Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report. BMC Infect Dis 9:49","journal-title":"BMC Infect Dis"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1471-2334-12-247","volume":"12","author":"VP Theodorou","year":"2012","unstructured":"Theodorou VP, Papaioannou VE, Tripsianis GA et al (2012) Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study. BMC Infect Dis 12:247","journal-title":"BMC Infect Dis"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/cc5067","volume":"10","author":"C Sponholz","year":"2006","unstructured":"Sponholz C, Sakr Y, Reinhart K, Brunkhorst F (2006) Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 10:R145","journal-title":"Crit Care"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2362.2010.02259.x","volume":"40","author":"P Schuetz","year":"2010","unstructured":"Schuetz P, Affolter B, Hunziker S et al (2010) Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort study. Eur J Clin Invest 40:376\u2013381","journal-title":"Eur J Clin Invest"},{"key":"16_CR43","first-page":"1477","volume":"51","author":"L Giovanella","year":"2013","unstructured":"Giovanella L, Verburg FA, Imperiali M et al (2013) Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules. Clin Chem Lab Med 51:1477\u20131481","journal-title":"Clin Chem Lab Med"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/cc7749","volume":"13","author":"H Brodska","year":"2009","unstructured":"Brodska H, Drabek T, Malickova K et al (2009) Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study. Crit Care 13:R37","journal-title":"Crit Care"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/CCM.0b013e318169eda9","volume":"36","author":"NP O\u2019Grady","year":"2008","unstructured":"O\u2019Grady NP, Barie PS, Bartlett JG et al (2008) Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 36:1330\u20131349","journal-title":"Crit Care Med"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock\u20142012. Crit Care Med 41: 580\u2013637","journal-title":"Crit Care Med"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhin.2010.07.026","volume":"77","author":"EJ Giamarellos-Bourboulis","year":"2011","unstructured":"Giamarellos-Bourboulis EJ, Tsangaris I, Kanni T et al (2011) Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study. J Hosp Infect 77:58\u201363","journal-title":"J Hosp Infect"},{"key":"16_CR48","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1186\/cc10087","volume":"15","author":"F Bloos","year":"2011","unstructured":"Bloos F, Marshall JC, Dellinger RP et al (2011) Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care 15:R88","journal-title":"Crit Care"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1186\/cc9327","volume":"14","author":"S Karlsson","year":"2010","unstructured":"Karlsson S, Heikkinen M, Pettila V et al (2010) Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 14:R205","journal-title":"Crit Care"},{"key":"16_CR50","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/cc12787","volume":"17","author":"P Schuetz","year":"2013","unstructured":"Schuetz P, Maurer P, Punjabi V et al (2013) Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care 17:R115","journal-title":"Crit Care"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jcrc.2010.07.012","volume":"26","author":"AP Georgopoulou","year":"2011","unstructured":"Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ et al (2011) Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care 26:331\u2013337","journal-title":"J Crit Care"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1097\/01.CCM.0000239116.01855.61","volume":"34","author":"JU Jensen","year":"2006","unstructured":"Jensen JU, Heslet L, Jensen TH et al (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34:2596\u20132602","journal-title":"Crit Care Med"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/cc7751","volume":"13","author":"PE Charles","year":"2009","unstructured":"Charles PE, Tinel C, Barbar S et al (2009) Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care 13:R38","journal-title":"Crit Care"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","volume":"363","author":"M Christ-Crain","year":"2004","unstructured":"Christ-Crain M, Jaccard-Stolz D, Bingisser R et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600\u2013607","journal-title":"Lancet"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","volume":"174","author":"M Christ-Crain","year":"2006","unstructured":"Christ-Crain M, Stolz D, Bingisser R et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174:84\u201393","journal-title":"Am J Respir Crit Care Med"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1378\/chest.06-1500","volume":"131","author":"D Stolz","year":"2007","unstructured":"Stolz D, Christ-Crain M, Bingisser R et al (2007) Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131:9\u201319","journal-title":"Chest"},{"key":"16_CR57","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.2009.1297","volume":"302","author":"P Schuetz","year":"2009","unstructured":"Schuetz P, Christ-Crain M, Thomann R et al (2009) Effect of procalcitonin-based guidelines vs. standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302: 1059\u20131066","journal-title":"JAMA"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1469-0691.2009.02709.x","volume":"15","author":"KB Kristoffersen","year":"2009","unstructured":"Kristoffersen KB, Sogaard OS, Wejse C et al (2009) Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission: a randomized trial. Clin Microbiol Infect 15:481\u2013487","journal-title":"Clin Microbiol Infect"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F et al (2010) Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463\u2013474","journal-title":"Lancet"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1183\/09031936.00053209","volume":"34","author":"D Stolz","year":"2009","unstructured":"Stolz D, Smyrnios N, Eggimann P et al (2009) Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 34:1364\u20131375","journal-title":"Eur Respir J"},{"key":"16_CR61","first-page":"382","volume":"33","author":"R Qu","year":"2012","unstructured":"Qu R, Ji Y, Ling Y et al (2012) Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial. Saudi Med J 33:382\u2013387","journal-title":"Saudi Med J"},{"key":"16_CR62","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","volume":"177","author":"V Nobre","year":"2008","unstructured":"Nobre V, Harbarth S, Graf JD et al (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177: 498\u2013505","journal-title":"Am J Respir Crit Care Med"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00423-008-0432-1","volume":"394","author":"S Schroeder","year":"2009","unstructured":"Schroeder S, Hochreiter M, Koehler T et al (2009) Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 394:221\u2013226","journal-title":"Langenbecks Arch Surg"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/cc7903","volume":"13","author":"M Hochreiter","year":"2009","unstructured":"Hochreiter M, Kohler T, Schweiger AM et al (2009) Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 13:R83","journal-title":"Crit Care"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000241296","volume":"97","author":"M Stocker","year":"2010","unstructured":"Stocker M, Fontana M, El HS et al (2010) Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology 97:165\u2013174","journal-title":"Neonatology"},{"key":"16_CR66","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1097\/CCM.0b013e318251517a","volume":"40","author":"N Layios","year":"2012","unstructured":"Layios N, Lambermont B, Canivet JL et al (2012) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 40:2304\u20132309","journal-title":"Crit Care Med"},{"key":"16_CR67","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1097\/CCM.0b013e31821e8791","volume":"39","author":"JU Jensen","year":"2011","unstructured":"Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39: 2048\u20132058","journal-title":"Crit Care Med"},{"key":"16_CR68","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/cid\/cis464","volume":"55","author":"P Schuetz","year":"2012","unstructured":"Schuetz P, Briel M, Christ-Crain M et al (2012) Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 55:651\u2013662","journal-title":"Clin Infect Dis"},{"key":"16_CR69","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/CCM.0b013e3181f17bf9","volume":"38","author":"P Kopterides","year":"2010","unstructured":"Kopterides P, Siempos II, Tsangaris I et al (2010) Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 38: 2229\u20132241","journal-title":"Crit Care Med"},{"key":"16_CR70","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s00134-012-2563-7","volume":"38","author":"DK Matthaiou","year":"2012","unstructured":"Matthaiou DK, Ntani G, Kontogiorgi M et al (2012) An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med 38:940\u2013949","journal-title":"Intensive Care Med"},{"key":"16_CR71","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1097\/CCM.0b013e31821201a5","volume":"39","author":"DK Heyland","year":"2011","unstructured":"Heyland DK, Johnson AP, Reynolds SC, Muscedere J (2011) Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med 39:1792\u20131799","journal-title":"Crit Care Med"},{"key":"16_CR72","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","volume":"41","author":"CF Oliveira","year":"2013","unstructured":"Oliveira CF, Botoni FA, Oliveira CR et al (2013) Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med 41:2336\u20132343","journal-title":"Crit Care Med"},{"key":"16_CR73","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/01.CCM.0000195012.54682.F3","volume":"34","author":"C Clec\u2019h","year":"2006","unstructured":"Clec\u2019h C, Fosse JP, Karoubi P et al (2006) Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 34:102\u2013107","journal-title":"Crit Care Med"},{"key":"16_CR74","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/cc5723","volume":"11","author":"K Kofoed","year":"2007","unstructured":"Kofoed K, Andersen O, Kronborg G et al (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11:R38","journal-title":"Crit Care"},{"key":"16_CR75","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/0885066608327095","volume":"24","author":"MJ Ruiz-Alvarez","year":"2009","unstructured":"Ruiz-Alvarez MJ, Garcia-Valdecasas S, De Pablo R et al (2009) Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 24:63\u201371","journal-title":"J Intensive Care Med"},{"key":"16_CR76","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1471-2334-9-213","volume":"9","author":"I Tsangaris","year":"2009","unstructured":"Tsangaris I, Plachouras D, Kavatha D et al (2009) Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay. BMC Infect Dis 9:213","journal-title":"BMC Infect Dis"},{"key":"16_CR77","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1440-1843.2010.01876.x","volume":"16","author":"KH Hsu","year":"2011","unstructured":"Hsu KH, Chan MC, Wang JM et al (2011) Comparison of Fcgamma receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients. Respirology 16:152\u2013160","journal-title":"Respirology"},{"key":"16_CR78","first-page":"594645","volume":"2011","author":"IA Meynaar","year":"2011","unstructured":"Meynaar IA, Droog W, Batstra M et al (2011) In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract 2011:594645","journal-title":"Crit Care Res Pract"},{"key":"16_CR79","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1471-2334-11-224","volume":"11","author":"N Bele","year":"2011","unstructured":"Bele N, Darmon M, Coquet I et al (2011) Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients. BMC Infect Dis 11:224","journal-title":"BMC Infect Dis"},{"key":"16_CR80","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jinf.2012.01.002","volume":"64","author":"SH Hoeboer","year":"2012","unstructured":"Hoeboer SH, Alberts E, van den Hul I et al (2012) Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin. J Infect 64:484\u2013493","journal-title":"J Infect"},{"key":"16_CR82","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/TA.0b013e31825ff5b7","volume":"73","author":"JV Sakran","year":"2012","unstructured":"Sakran JV, Michetti CP, Sheridan MJ, et al (2012) The utility of procalcitonin in critically ill trauma patients. J Trauma Acute Care Surg 73:413\u2013418","journal-title":"J Trauma Acute Care Surg"}],"container-title":["Methods in Molecular Biology","Sepsis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-1776-1_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:28:45Z","timestamp":1559003325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-1776-1_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,24]]},"ISBN":["9781493917754","9781493917761"],"references-count":82,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-1776-1_16","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-1776-1","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,24]]}}}